Genomic Vision Stock Soars 23% In 10 Sessions: What’s Driving The Surge?
(VIANEWS) – Genomic Vision (GV.PA), a biotech company listed on France’s CAC 40 index, has recently attracted renewed investor attention. Over 10 trading sessions, its shares soared 23.46% – moving from EUR0.01 to EUR0.01, as of 16:08 EST Friday afternoon – following yesterday’s positive performance by both Genomic Vision’s stock price and CAC 40 index…